Home Latest Stories Pfizer Starts mRNA Flu Vaccine Trial, Designed Like Its Covid Jab

Pfizer Starts mRNA Flu Vaccine Trial, Designed Like Its Covid Jab


Pfizer Starts mRNA Flu Vaccine Trial, Designed Like Its Covid Jab

US pharmaceutical company Pfizer begun a clinical trial to test an influenza vaccine.

Washington:

US pharmaceutical company Pfizer said Monday it had begun a clinical trial to test an influenza vaccine designed with the same mRNA technology behind its successful Covid-19 shot.

The idea is to improve on the current generation of flu vaccines that have an efficacy of 40-60 percent against a disease that can cause up to 650,000 deaths a year.

“The Covid-19 pandemic allowed us to deliver on the immense scientific opportunity of mRNA,” Kathrin Jansen, head of vaccine research at Pfizer, said in a statement.

“Influenza remains an area where we see a need for vaccines which could result in improved efficacy in any given season, and we believe mRNA is the ideal technology to take on this challenge.”

The early stage study will recruit more than 600 Americans aged 65 to 85, according to a company statement and a government website listing the trial.

Specifically, Pfizer wants to compare the safety and level of immune response of a single, double and quadruple strain mRNA vaccine at different dosage levels versus a conventional, licensed quadruple strain vaccine.

Conventional seasonal flu vaccines are generally cultured by growing the virus inside chicken eggs or mammalian cells.

The viruses are inactivated and processed to be turned into vaccines.

The process is fraught with challenges, including producing vaccines that evoke a strong response and keeping up with virus strain changes.

Experts have to predict the best match for next season’s vaccine six months out.

The promise of mRNA (messenger ribonucleic) acid technology is that they only require the genetic sequence of the virus, or a specific part of it, enabling faster and more flexible production.

The human body reads the genetic code and produces virus-like cells that train the immune system to be prepared for the real thing.

Pfizer began work on its mRNA influenza vaccine in 2018 with its German partner BioNTech, which would receive a royalty upon approval and commercialization.

In the future, Pfizer plans to explore mRNA medicine against other respiratory viruses, cancer and genetic diseases.

Moderna likewise is working on an mRNA flu vaccine and one against respiratory syncytial virus (RSV).

(This story has not been edited by NDTV staff and is auto-generated from a syndicated feed.)



Source link

RELATED ARTICLES

Judge Approves Name Change Request

<!-- -->Artist Kanye West's name is now officially Ye.New York: The artist formerly known as Kanye West is now officially Ye.Just Ye.A Los...

US Accuses Venezuela’s Nicolas Maduro Of Putting Extradited Businessman Above Country

<!-- -->Alex Saab was accused of acting as money launderer for Venezuelan President Nicolas Maduro.Washington: The United States on Monday criticized Venezuelan leader...

Boris Johnson Government Under Spotlight As Covid Cases Rise In UK Again

<!-- -->UK Prime Minister Boris Johnson government is in spotlight amid rise in Covid cases.London: Britain has repeatedly trumpeted its mass vaccination programme...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

US Says No Offer Made To Turkey For Sale Of F-16 Jets After Erdogan’s Comment

<!-- -->Turkish President Erdogan said that United States had proposed sale of F-16 fighter jets to Turkey.Washington: The United States on Monday did...

Judge Approves Name Change Request

<!-- -->Artist Kanye West's name is now officially Ye.New York: The artist formerly known as Kanye West is now officially Ye.Just Ye.A Los...

Former US President Donald Trump Testifies Over Bodyguards’ 2015 Clash With Protesters: Lawyer

<!-- -->Ex-president Donald Trump testified in the lawsuit today, lawyer said. (File)New York: Ex-president Donald Trump testified Monday in a lawsuit brought by...

Faulted For Hasty Withdrawal, US Envoy On Afghanistan Zalmay Khalilzad Quits

<!-- -->Afghanistan: The United States forces left Afghanistan on August 31. (File)Washington: Zalmay Khalilzad, the veteran US envoy whose months of hotel-ballroom diplomacy...

Recent Comments